Piramal Pharma shares have gained 2% ahead of its Q2FY25 earnings results, with investor optimism driving the stock up.
Opening at ₹214.05, the stock reached a high of ₹221.65, with a low of ₹209.45 during the trading session. The company’s 52-week high stands at ₹244.10, while its 52-week low is ₹87.55.
With market momentum building, Piramal Pharma remains a key stock to watch as its Q2FY25 results could further influence investor sentiment.
As of 10:53 am, Piramal Pharma shares were trading 2.23% higher at Rs 219.95 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information
